193 related articles for article (PubMed ID: 27374062)
1. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
2. A distal regulatory region of a class I human histone deacetylase.
Werbeck ND; Shukla VK; Kunze MBA; Yalinca H; Pritchard RB; Siemons L; Mondal S; Greenwood SOR; Kirkpatrick J; Marson CM; Hansen DF
Nat Commun; 2020 Jul; 11(1):3841. PubMed ID: 32737323
[TBL] [Abstract][Full Text] [Related]
3. On the inhibition of histone deacetylase 8.
Estiu G; West N; Mazitschek R; Greenberg E; Bradner JE; Wiest O
Bioorg Med Chem; 2010 Jun; 18(11):4103-10. PubMed ID: 20472442
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities.
Shetty MG; Pai P; Dey B; Satyamoorthy K; Shil S; Nayak UY; T A; Sundara BK
Daru; 2024 Jun; 32(1):263-278. PubMed ID: 38683491
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Histone Deacetylase 8 Inhibitor through Drug Screenings Based on Machine Learning.
Nurani A; Yamashita Y; Taki Y; Takada Y; Itoh Y; Suzuki T
Chem Pharm Bull (Tokyo); 2024; 72(2):173-178. PubMed ID: 38296560
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors and cell death.
Zhang J; Zhong Q
Cell Mol Life Sci; 2014 Oct; 71(20):3885-901. PubMed ID: 24898083
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic histone deacetylase inhibitors.
Mwakwari SC; Patil V; Guerrant W; Oyelere AK
Curr Top Med Chem; 2010; 10(14):1423-40. PubMed ID: 20536416
[TBL] [Abstract][Full Text] [Related]
8. HDAC8 substrates: Histones and beyond.
Wolfson NA; Pitcairn CA; Fierke CA
Biopolymers; 2013 Feb; 99(2):112-26. PubMed ID: 23175386
[TBL] [Abstract][Full Text] [Related]
9. Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.
Osko JD; Christianson DW
Acta Crystallogr F Struct Biol Commun; 2020 Sep; 76(Pt 9):428-437. PubMed ID: 32880591
[TBL] [Abstract][Full Text] [Related]
10. Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.
Hanigan TW; Aboukhatwa SM; Taha TY; Frasor J; Petukhov PA
Cell Chem Biol; 2017 Nov; 24(11):1356-1367.e8. PubMed ID: 28943357
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).
Luo Y; Li H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266366
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.
Welker Leng KR; Castañeda CA; Decroos C; Islam B; Haider SM; Christianson DW; Fierke CA
Biochemistry; 2019 Nov; 58(45):4480-4493. PubMed ID: 31633931
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.
Jha S; Kim JH; Kim M; Nguyen AH; Ali KH; Gupta SK; Park SY; Ha E; Seo YH
Eur J Med Chem; 2024 Feb; 265():116057. PubMed ID: 38142511
[TBL] [Abstract][Full Text] [Related]
14. Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout.
Steimbach RR; Herbst-Gervasoni CJ; Lechner S; Stewart TM; Klinke G; Ridinger J; Géraldy MNE; Tihanyi G; Foley JR; Uhrig U; Kuster B; Poschet G; Casero RA; Médard G; Oehme I; Christianson DW; Gunkel N; Miller AK
J Am Chem Soc; 2022 Oct; 144(41):18861-18875. PubMed ID: 36200994
[TBL] [Abstract][Full Text] [Related]
15. Discovery of histone deacetylase 8 selective inhibitors.
Tang W; Luo T; Greenberg EF; Bradner JE; Schreiber SL
Bioorg Med Chem Lett; 2011 May; 21(9):2601-5. PubMed ID: 21334896
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Identification of HDAC8 Non-histone Substrates.
Alam N; Zimmerman L; Wolfson NA; Joseph CG; Fierke CA; Schueler-Furman O
Structure; 2016 Mar; 24(3):458-68. PubMed ID: 26933971
[TBL] [Abstract][Full Text] [Related]
17. Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy.
Spreafico M; Cafora M; Bragato C; Capitanio D; Marasca F; Bodega B; De Palma C; Mora M; Gelfi C; Marozzi A; Pistocchi A
Pharmacol Res; 2021 Aug; 170():105750. PubMed ID: 34214631
[TBL] [Abstract][Full Text] [Related]
18. Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel.
Wu R; Lu Z; Cao Z; Zhang Y
J Am Chem Soc; 2011 Apr; 133(16):6110-3. PubMed ID: 21456530
[TBL] [Abstract][Full Text] [Related]
19. HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.
Castañeda CA; Wolfson NA; Leng KR; Kuo YM; Andrews AJ; Fierke CA
J Biol Chem; 2017 Dec; 292(52):21568-21577. PubMed ID: 29109148
[TBL] [Abstract][Full Text] [Related]
20. Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency.
Pan Y; Hou H; Zhou B; Gao J; Gao F
Eur J Med Chem; 2023 Dec; 262():115879. PubMed ID: 37875056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
